Latest annual review on HIV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.

The World Health Organization’s Global TB Program has established a Global Civil Society Task Force on TB to enhance the engagement of communities, non-governmental and other civil society organizations in the implementation of the End TB Strategy.

Stop TB Partnership and UNAIDS launch first gender assessment tool for national HIV and TB responses to support countries with applications to the Global Fund.

TB activists urge the Drug Controller General of India to withdraw GeneDrive test for TB from the Indian market.

The Stop TB Partnership launches a call for nominations to join the Proposal Review Committee for Wave 5 of TB REACH.

Health and Human Rights Journal Special Section on tuberculosis and the right to health.

TB advocates urge the Ministry of Health in Cote d’Ivoire to introduce a new, simple, and rapid TB test, TB LAM, which detects TB antigens in urine, and is an important tool for detecting TB in certain populations living with HIV.

The update informs about the general progress in the introduction of bedaquiline and delamanid in TB programs worldwide and reports on the requests made in the Call to Action issued in March 2015.

The Stop TB Partnership signed a Memorandum of Understanding with the Global Fund to Fight AIDS, Tuberculosis and Malaria to optimize access to TB health products and pharmaceutical services in countries receiving Global Fund financing for TB.

Treatment Action Group released a new resource, Breathing Life into Flatlined U.S. Government Funding for Tuberculosis Research: FY 2017–2020 Allocations and Recommendation, to spark and support ongoing advocacy on TB R&D.